π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The aim of this study is to compare the efficacy of intravenous sedation us...
Status
Completed
Location
Tanta University
Start Date
2024-11-01
Trial ID
NCT07580768
Treatments Being Tested
The study aims to compare procedural sedation protocols, specifically appli...
Status
Unknown
Location
Katholieke Universiteit Leuven
Start Date
2013-12
Trial ID
NCT02078336
Treatments Being Tested
The purpose of the study is to study the effects of BMS-955176 on the singl...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-09
Trial ID
NCT02578277
This is an open-label, fixed-sequence Phase I clinical trial to evaluate th...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-27
Trial ID
NCT07685041
Treatments Being Tested
The main objectives of this phase 1 trial are to evaluate the effect of foo...
Status
Completed
Location
Investigator Site
Start Date
2017-01-01
Trial ID
NCT03017495
Treatments Being Tested
The aim of our study was to compare the effects of interscalene block alone...
Status
Recruiting
Location
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Start Date
2026-02-23
Trial ID
NCT07398352
The primary aim is to determine the difference in hospital length of stay b...
Status
Completed
Location
Advocate Christ Medical Center
Start Date
2007-10
Trial ID
NCT00441792
The study's aim is to ascertain the best approach for providing sedation an...
Status
Recruiting
Location
Long Beach Memorial Medical Center
Start Date
2023-04-01
Trial ID
NCT05751863
The objective of this study is to evaluate the effect of multiple doses of ...
Status
Completed
Location
Celerion
Start Date
2025-10-07
Trial ID
NCT07235748
Treatments Being Tested
This is a single-center, randomized, open-label, 3 parallel treatment study...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01
Trial ID
NCT01754116